Marja Hallström

858 total citations
24 papers, 694 citations indexed

About

Marja Hallström is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marja Hallström has authored 24 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marja Hallström's work include Colorectal Cancer Treatments and Studies (17 papers), Genetic factors in colorectal cancer (12 papers) and Gastric Cancer Management and Outcomes (5 papers). Marja Hallström is often cited by papers focused on Colorectal Cancer Treatments and Studies (17 papers), Genetic factors in colorectal cancer (12 papers) and Gastric Cancer Management and Outcomes (5 papers). Marja Hallström collaborates with scholars based in Sweden, Australia and Germany. Marja Hallström's co-authors include David Edler, Peter Ragnhammar, Henric Blomgren, Katarina Öhrling, Patrick G. Johnston, I Magnusson, Bengt Glimelius, Anders Jakobsen, Magnus Ingelman‐Sundberg and Maria Karlgren and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and European Journal of Cancer.

In The Last Decade

Marja Hallström

24 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marja Hallström Sweden 11 542 228 159 153 153 24 694
Allyson L. Parr United States 12 711 1.3× 250 1.1× 153 1.0× 305 2.0× 297 1.9× 15 1.0k
Chien-Yu Lu Taiwan 13 455 0.8× 128 0.6× 103 0.6× 187 1.2× 145 0.9× 17 606
Domizia Debernardis Italy 11 577 1.1× 191 0.8× 98 0.6× 236 1.5× 131 0.9× 16 692
Bernardo Queralt Spain 13 487 0.9× 102 0.4× 100 0.6× 172 1.1× 269 1.8× 23 675
Alexander Huether Germany 11 344 0.6× 182 0.8× 120 0.8× 431 2.8× 176 1.2× 12 903
W Zhang United States 12 367 0.7× 119 0.5× 66 0.4× 304 2.0× 115 0.8× 21 608
G. Catalano Italy 11 450 0.8× 129 0.6× 113 0.7× 181 1.2× 206 1.3× 34 640
J Llory France 2 1.0k 1.9× 196 0.9× 258 1.6× 151 1.0× 268 1.8× 2 1.2k
Hitoyasu Futami Japan 16 420 0.8× 52 0.2× 115 0.7× 330 2.2× 115 0.8× 41 869
Silvia Böhm Italy 11 341 0.6× 218 1.0× 126 0.8× 187 1.2× 78 0.5× 24 679

Countries citing papers authored by Marja Hallström

Since Specialization
Citations

This map shows the geographic impact of Marja Hallström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja Hallström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja Hallström more than expected).

Fields of papers citing papers by Marja Hallström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja Hallström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja Hallström. The network helps show where Marja Hallström may publish in the future.

Co-authorship network of co-authors of Marja Hallström

This figure shows the co-authorship network connecting the top 25 collaborators of Marja Hallström. A scholar is included among the top collaborators of Marja Hallström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja Hallström. Marja Hallström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hallström, Marja, et al.. (2018). Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer – An Exploratory Analysis. Anticancer Research. 38(8). 4713–4721. 8 indexed citations
2.
Hallström, Marja, et al.. (2016). HER3 expression is correlated to distally located and low-grade colon cancer. Acta Oncologica. 55(7). 875–880. 9 indexed citations
3.
Hallström, Marja, et al.. (2015). HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver. Acta Oncologica. 54(4). 480–486. 16 indexed citations
4.
Hallström, Marja, et al.. (2014). The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases. Acta Oncologica. 53(7). 885–891. 17 indexed citations
5.
Zheng, Yujuan, Stéphane Audebert, Per Johnsson, et al.. (2014). AmotL2 disrupts apical–basal cell polarity and promotes tumour invasion. Nature Communications. 5(1). 4557–4557. 51 indexed citations
6.
Hallström, Marja, et al.. (2013). HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome. European Journal of Cancer. 50(3). 656–662. 44 indexed citations
7.
Öhrling, Katarina, et al.. (2012). A Combined Analysis of Mismatch Repair Status and Thymidylate Synthase Expression in Stage II and III Colon Cancer. Clinical Colorectal Cancer. 12(2). 128–135. 7 indexed citations
8.
Öhrling, Katarina, David Edler, Marja Hallström, & Peter Ragnhammar. (2010). Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer. Acta Oncologica. 49(6). 797–804. 25 indexed citations
9.
Öhrling, Katarina, et al.. (2010). Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.. PubMed. 30(2). 645–51. 31 indexed citations
10.
Edler, David, Katarina Öhrling, Marja Hallström, et al.. (2008). The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer – A pilot study. European Journal of Cancer. 45(4). 705–712. 41 indexed citations
11.
Öhrling, Katarina, David Edler, Marja Hallström, & Peter Ragnhammar. (2008). Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours.. PubMed. 28(3B). 1741–7. 6 indexed citations
12.
Edler, David, et al.. (2007). The number of analyzed lymph nodes – a prognostic factor in colorectal cancer. Acta Oncologica. 46(7). 975–981. 66 indexed citations
13.
Öhrling, Katarina, et al.. (2007). Immunohistochemical test for MLH1 and MSH2 is an independent prognostic factor in sporadic colorectal cancer. Journal of Clinical Oncology. 25(18_suppl). 4126–4126. 1 indexed citations
14.
Edler, David, Bengt Glimelius, Marja Hallström, et al.. (2002). Thymidylate Synthase Expression in Colorectal Cancer: A Prognostic and Predictive Marker of Benefit From Adjuvant Fluorouracil-Based Chemotherapy. Journal of Clinical Oncology. 20(7). 1721–1728. 210 indexed citations
15.
Blomgren, Henric, et al.. (1991). Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. Its potential use in the treatment of superficial bladder cancer.. PubMed. 11(2). 773–6. 5 indexed citations
16.
Blomgren, Henric & Marja Hallström. (1991). Inhibition of tumor cell growth in vitro by 2-mercaptoethanesulfonate (mesna) and other thiols.. PubMed. 13(8). 579–82. 1 indexed citations
17.
Blomgren, Henric & Marja Hallström. (1991). Possible role of acrolein in 4-hydroperoxycyclophosphamide-induced cell damage in vitro.. PubMed. 13(1). 11–4. 10 indexed citations
18.
Blomgren, Henric & Marja Hallström. (1990). Possible role of acrolein in oxazaphosphorine-induced enhancement of immunological reactivity. Cancer Immunology Immunotherapy. 31(4). 221–225. 3 indexed citations
19.
Blomgren, Henric, et al.. (1990). Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro.. PubMed. 12(10). 691–7. 5 indexed citations
20.
Blomgren, Henric & Marja Hallström. (1989). Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells.. PubMed. 11(6). 391–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allyson L. Parr Breakdown of academic impact, for papers by Chien-Yu Lu Breakdown of academic impact, for papers by Domizia Debernardis Breakdown of academic impact, for papers by Bernardo Queralt Breakdown of academic impact, for papers by Alexander Huether Breakdown of academic impact, for papers by W Zhang Breakdown of academic impact, for papers by G. Catalano Breakdown of academic impact, for papers by J Llory Breakdown of academic impact, for papers by Hitoyasu Futami Breakdown of academic impact, for papers by Silvia Böhm
Rankless by CCL
2026